Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2008; 14(19): 3038-3043
Published online May 21, 2008. doi: 10.3748/wjg.14.3038
Published online May 21, 2008. doi: 10.3748/wjg.14.3038
Table 2 Response rate in patients with HBeAg positive chronic hepatitis B by interferon-β treatment (%)
| wk 1 | wk 2 | End of the treatment | 6 mo after treatment | |
| HBV-DNA negative | 5/26 (19.2) | 5/26 (19.2) | 10/26 (38.5) | 13/26 (50.0) |
| HBeAg and HBV-DNA negative | 4/26 (15.4) | 9/26 (34.6) |
- Citation: Okushin H, Ohnishi T, Morii K, Uesaka K, Yuasa S. Short-term intravenous interferon therapy for chronic hepatitis B. World J Gastroenterol 2008; 14(19): 3038-3043
- URL: https://www.wjgnet.com/1007-9327/full/v14/i19/3038.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3038